1. Medtech Insight

Neovasc’s Reducer Shows Promise For Refractory Angina

In a small but sham-controlled trial Neovasc’s balloon-expandable implant significantly improved symptoms and quality of life in patients with refractory angina who are not candidates for other revascularization procedures. Reducer works by increasing pressure in the coronary sinus.

Neovasc Medical Ltd.’s Reducer percutaneous coronary-sinus implant may provide relief of debilitating chronic angina in patients with no other alternative, according to the results of the sham-controlled Coronary Sinus Reducer for Treatment of Refractory Angina (COSIRA

) trial.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight